• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Tegaserod maleate

CAS No. 189188-57-6

Tegaserod maleate ( SDZ-HTF 919; Zelnorm )

产品货号. M12965 CAS No. 189188-57-6

Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation.

纯度: >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
10MG ¥316 有现货
25MG ¥583 有现货
50MG ¥988 有现货
100MG ¥1693 有现货
200MG ¥2568 有现货
500MG ¥4334 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Tegaserod maleate
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation.
  • 产品描述
    Tegaserod is a 5-HT4 agonist manufactured by Novartis and used for the management of irritable bowel syndrome and constipation. Its use was the only drug approved by the United States Food and Drug Administration to help relieve the abdominal discomfort, bloating and constipation associated with irritable bowel syndrome.
  • 同义词
    SDZ-HTF 919; Zelnorm
  • 通路
    Endocrinology/Hormones
  • 靶点
    5-HT Receptor
  • 受体
    5-HT; Sert (Sodium-dependent)
  • 研究领域
    Neurological Disease
  • 适应症
    ——

化学信息

  • CAS Number
    189188-57-6
  • 分子量
    417.46
  • 分子式
    C20H27N5O5
  • 纯度
    >98%(HPLC)
  • 溶解度
    DMSO: 35mg/mL
  • SMILES
    CCCCCN=C(N)NN/C=C/1\C=NC2=C1C=C(C=C2)OC.C(=C\C(=O)O)\C(=O)O
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1.Beattie DT, et al. Br J Pharmacol. 2004 Nov;143(5):549-60.
产品手册
关联产品
  • Almotriptan

    Almotriptan is a 5-HT1B/1D-receptor agonist used to treat migraine.Almotriptan is a triptan drug for treatment of migraine headaches.

  • SUVN-502 mesylate

    SUVN-502 (SUVN502)is a potent, selective, brain penetrant and orally active 5-HT6 receptor antagonist with Ki of 2.04 nM.

  • Molindone hydrochlor...

    Molindone is a therapeutic antipsychotic, used in the treatment of schizophrenia, works by blocking the effects of dopamine in the brain, leading to diminished psychoses.